Compare TRDA & ISSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRDA | ISSC |
|---|---|---|
| Founded | 2016 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 438.8M | 380.6M |
| IPO Year | 2021 | 2000 |
| Metric | TRDA | ISSC |
|---|---|---|
| Price | $12.68 | $26.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $20.00 | $16.50 |
| AVG Volume (30 Days) | 189.4K | ★ 480.4K |
| Earning Date | 05-25-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 120.00 |
| EPS | N/A | ★ 0.22 |
| Revenue | ★ $25,421,000.00 | N/A |
| Revenue This Year | $51.37 | $6.63 |
| Revenue Next Year | $46.98 | $8.13 |
| P/E Ratio | ★ N/A | $128.77 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.93 | $5.30 |
| 52 Week High | $12.93 | $29.41 |
| Indicator | TRDA | ISSC |
|---|---|---|
| Relative Strength Index (RSI) | 59.74 | 58.89 |
| Support Level | $9.59 | $17.57 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.84 | 1.91 |
| MACD | 0.07 | 0.26 |
| Stochastic Oscillator | 85.96 | 65.12 |
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.
Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.